Please login to the form below
clinical
This page shows the latest clinical news and features for those working in and with pharma, biotech and healthcare.
Inovio hit with FDA hold on COVID-19 vaccine trial
Importantly, the clinical hold is not due to the occurrence of any adverse events related to the vaccine, Inovio said in the statement. ... Currently, Inovio has 15 DNA medicine clinical programmes in development focused on HPV-associated diseases,
Latest news
-
Researchers call on Pfizer to delay COVID-19 vaccine application
They added that Pfizer’s clinical trial needs to monitor participants for at least another two months after they have received a second dose of the vaccine candidate, BNT162b2. ... Pfizer is among a number of top companies that signed a pledge earlier
-
J&J advances COVID-19 vaccine into phase 3 testing
1/2a clinical study of the shot. ... In a separate principle agreement, J&J will also collaborate with the UK government on a phase 3 clinical trial in multiple countries to explore a two-dose regimen of its
-
Phase 1/2a results for J&J’s COVID-19 vaccine show early promise
High levels of neutralising antibodies are an important indicator of efficacy in early clinical trials, as they defend cells from pathogens, including SARS-CoV-2. ... In addition, J&J reported that similar immunogenicity was observed across both dose
-
EU will shoulder certain liability costs in AZ COVID-19 vaccine deal
Low-cost deal will see the EU assume responsibility for side-effect claims
-
Lilly’s Verzenio scores a win in early-stage breast cancer
Positive data was presented at 2020 ESMO virtual congress
More from news
Approximately 192 fully matching, plus 4,592 partially matching documents found.
Latest Intelligence
-
Switzerland: a life sciences hub
Switzerland has a rich diversity of pharma and biotech companies that sustain activity and help maintain its reputation as a highly innovative country
-
Taking a holistic approach to patient care
In a clinical environment, it is easy to assume that treating or curing the physical symptoms of a disease is the priority for a patient. ... Alongside clinical appointments, patients are offered a holistic needs assessment, followed by a referral to the
-
Surviving cancer: a new era for patients
Monoclonal antibodies have given rise to many promising therapies with equally promising clinical results. ... The rise of the monoclonal antibody. Trastuzumab was the first monoclonal antibody tested in clinical trials, designed to inhibit human
-
How COVID-19 is accelerating the threat of antimicrobial resistance
Some of the organisations most engaged with by HCPs included the Royal Pharmaceutical Society (RPS) and the UK Clinical Pharmacy Association (UKCPA).
-
BiTE* platform and the evolution toward off-the-shelf immuno-oncology approaches
Amgen Oncology, one of the leading developers of innovative therapies for novel targets in difficult-to-treat cancers, is working to bring new hope for transforming clinical outcomes for patients with
More from intelligence
Approximately 18 fully matching, plus 631 partially matching documents found.
Latest appointments
-
New hires at EMA, Gilead and BeiGene
In this role, Genovese will oversee the clinical development of Gilead’s investigational portfolio of treatments for inflammatory conditions. ... Raitt professor of medicine and clinical chief in the division of immunology and rheumatology.
-
Syneos Health appoints Tim Pantello as president of communications
Our entire model is about acceleration and our Communications organisation is built on agility and speed beyond big creative and standalone strategy, scale, clinical and scientific depth, skill and a ... Our ability to bring multiple disciplines together
-
Azafaros expands executive team with three senior hires
He joins from Helsinn Group, where he held the position of global head of clinical research and development. ... Prior to this, he held global clinical development and medical affairs leadership roles at Actelion Pharmaceuticals.
-
Ashfield appoints new global head of quality and compliance
Clinical. “Since joining Ashfield, Carey has transformed our Quality and Compliance department here in the US, creating a key differentiator for Ashfield and providing a valuable client service.
-
NICE looks internally for new chief executive
Originally training in medicine, Leng went on to work on clinical trials and epidemiological research as well as a consultant in public health medicine. ... During her time at NICE, she held responsibility for setting up and running the clinical
More from appointments
Approximately 3 fully matching, plus 524 partially matching documents found.
Latest from PMHub
-
World Heart Day 2020: It's time to make our clinical trials more inclusive
There are many challenges to overcome to increase diversity in clinical trials, which overlap with the barriers mentioned above. ... Here at COUCH Health, we know the importance of diversity and inclusion in clinical trials.
-
Responding to dynamic shifts in value communications
Furthermore, these rapidly changing definitions of value have led to a convergence of clinical and health economics outcomes research (HEOR) communications, which are frequently presented together to deliver an integrated value
-
Webinar: Maintaining market access through a pandemic, 6 months on
proof. Join our esteemed speaker panel, consisting of:. Leslie Galloway: Expert Adviser at the NICE Centre for Clinical Practice and Chairman of the Ethical Medicines Industry Group (EMIG).
-
3 ways to increase patient retention rates in clinical trials
Retention rates are falling in clinical trials. Yes, it is a bit disheartening. ... All without actually speaking to them. So how do they know if the clinical study is really going to help their patients, without their insights?
-
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise. ... And the hard truth is, just because more patients are signing up to take part in a clinical study, there’s nothing stopping them from leaving
More from PMHub
Approximately 95 fully matching, plus 549 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Lilly’s Verzenio scores a win in early-stage breast cancer
- Relief Therapeutics seeks US emergency approval for COVID-19 drug
- FDA hands BMS and bluebird bio a priority review for ide-cel
- Keytruda doubles five-year survival rate in NSCLC
- FDA approves Roche’s Actemra COVID-19 trial
PMHub
Apex.co.uk Events and Exhibition Stands
Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...
Latest intelligence
- Switzerland: a life sciences hub
- Switzerland has a rich diversity of pharma and biotech companies that sustain activity and help maintain its reputation as a highly innovative country...
- Responding to dynamic shifts in value communications
- OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceutical companies....
- Doing what we can and having fun doing it: our fundraising month
- Charities are facing a number of challenges just to stay afloat amidst the current COVID-19 pandemic. Fundraisers are being cancelled and public donations are not as abundant as they have...
Quick links
Infographics
